Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income	$ 35,074,880	$ 12,109,956
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and other amortization	274,294	279,310
Stock-based compensation	2,136,719	2,062,297
Write down of inventory, net	471,971	327,373
Deferred income taxes, net	6,887,501	(563,807)
Deferred IV TPOXX® revenue	(90,800)	(7,059,280)
Changes in assets and liabilities:
Accounts receivable	14,679,752	12,176,518
Inventory	13,474,873	9,036,113
Prepaid expenses and other assets	306,137	(2,498,377)
Accounts payable, accrued expenses and other liabilities	773,484	(4,426,482)
Income tax payable	(3,842,106)	(21,608,443)
Net cash provided by/(used in) operating activities	70,146,705	(164,822)
Cash flows from investing activities:
Capital expenditures	(24,894)	(2,185)
Cash used in investing activities	(24,894)	(2,185)
Cash flows from financing activities:
Payment of employee tax obligations for common stock tendered	(192,306)	(355,539)
Payment of dividend	(42,866,683)	(42,673,512)
Cash used in financing activities	(43,058,989)	(43,029,051)
Net increase/(decrease) in cash and cash equivalents	27,062,822	(43,196,058)
Cash and cash equivalents at the beginning of period	155,400,262	150,145,844
Cash and cash equivalents at end of period	182,463,084	106,949,786
Supplemental disclosure of non-cash financing activities:
Non-cash lease right-of-use asset and associated liability	0	462,686
Issuance of common stock	$ 0	$ 417,000